MedPath

effect of Gemfibrozil for treatment of cigarette

Not Applicable
Conditions
nicotine dependence.
Mental and behavioural disorders due to use of tobacco
Registration Number
IRCT2017101732057N3
Lead Sponsor
Vice chancellor for research of Kashan University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
76
Inclusion Criteria

Having an age of 19–65 years; nicotine dependence based on DSM 5; lack of history of psychotic disorders; having negative results in opioid and amphetamines test; lacking diagnosis of chronic disease such as debate, blood pressure , cancer and etc; Not be pregnant. Exclusion criteria: Unwillingness to continue participating in the study; being pregnancy during study; uses drugs with contraindication or Interference with Gemfibrozil such as Anticoagulants, statins, other fibrates and niacin.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Smoking cessation. Timepoint: Before intervention; 1,2,3,4,5,6,7,8,11,14,19 after beginning of intervention. Method of measurement: Expiratory CO2 concentration.;Nicotine dependence. Timepoint: Before intervention; 1,2,3,4,5,6,7,8,11,14,19 after beginning of intervention. Method of measurement: fagestrom nicotine dependence scale.;Nicotine Withdrawal. Timepoint: Before intervention; 1,2,3,4,5,6,7,8,11,14,19 after beginning of intervention. Method of measurement: Minnesota Nicotine Withdrawal Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath